KCT0002179
Recruiting
未知
Clinical study evaluates the safety and efficacy of the OA Kneetrac CHANGEUI MEDICAL co., Ltd. for patients with knee joint osteoarthritis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the musculo-skeletal system and connective tissue
- Sponsor
- Chonbuk National University Hospital
- Enrollment
- 40
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Adults over 20 years old
- •2\) Diagnosis: Osteoarthritis of the Knee
- •3\) In the anteroposterior x\-ray of the knee in a standing position according to the scale Kellgren\-Lawrence (K\-L) patient received ?, ? grade diagnosis
- •4\) The patient has subscribed the informed consent
Exclusion Criteria
- •1\) The patients with lower extremity surgical treatments and cortisone injections for those who receive treatment within the last 3 months. (Steroidal and non\-steroidal anti\-inflammatory drug treatments, such as drugs does not limit)
- •2\) The patients with ligaments injury, knee joint infection, inflammatory joint disease, fibromyalgia, symptoms of nerve root compression in the spine, central nervous system diseases, polyneuropathy, cognitive disorders, etc.
- •3\) Principal investigator who is deemed unsuitable for clinical trial participation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 4
A study to assess the safety and efficacy of Poly-L-lactic acid dermal fillers in the treatment of facial ageingFacial ageingNot ApplicableISRCTN66942709Sinclair Pharma142
Recruiting
Not Applicable
Clinical study to evaluate safety and efficacy of OA Kneetrac (SP1000 ™) of Changmi Medical Co. in patients with degenerative knee arthritisDiseases of the musculo-skeletal system and connective tissueKCT0003907Chonbuk National University Hospital30
Completed
Phase 3
Clinical Trial of S-Amlodipine , Olmesartan and Hydrochlorothiazide combination tablet in the treatment of HypertensioCTRI/2011/06/001820Emcure Pharmaceuticals Ltd Pune200
Unknown
Phase 3
Clinical Study to assess the efficacy and safety of increased dose of TA-650 in patients with Rheumatoid ArthritisRheumatoid ArthritisJPRN-jRCT2080220144Mitsubishi Tanabe Pharma Corporation
Completed
Phase 3
Clinical Trial of S-Metoprolol , Atorvastatin and Ramipril combination tablet in the treatment of HypertensioCTRI/2011/06/001818Emcure Pharmaceuticals Ltd Pune200